Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Carbometyx
Carbometyx
Cabometyx study ends early after researchers see 'dramatic' benefits in neuroendocrine tumors, Exelixis says
Fierce Pharma
Thu, 08/24/23 - 08:37 pm
Carbometyx
Exelixis
clinical trials
neuroendocrine tumors
Exelixis and Ipsen to seek approval for Cabometyx in prostate cancer
Clinical Trials Arena
Mon, 08/21/23 - 10:02 am
Exelixis
Ipsen
Carbometyx
prostate cancer